ABL Bio
298380.KQ
65.15 USD
0.25
+0.39%
a
Overview
Last close
65.15 usd
Market cap
3.16B usd
52 week high
77.86 usd
52 week low
15.54 usd
Target price
59.83 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
47.3366
Price/Book Value
25.7204
Enterprise Value
3.20B usd
EV/Revenue
48.0588
EV/EBITDA
-32.1061
Key financials
Revenue TTM
66.50M usd
Gross Profit TTM
66.47M usd
EBITDA TTM
-13.59M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
180.43M usd
Net debt
N/A usd
About
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is based in Seoul, South Korea.
- Symbol298380.KQ
- ExchangeKQ
- IsinKR7298380007
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Sang Hoon Lee Ph.D.
- HeadquarterSeoul
- Web sitehttps://www.ablbio.com
